【光大研究每日速递】20251022

Macro Insights - The recent surge in gold prices is attributed to multiple factors including renewed US-China trade tensions, Powell's indication of ending balance sheet reduction, and regional bank failures in the US. This has led to increased capital inflow into the gold market. Although short-term bullish factors are fully priced in, the long-term bull market for gold is far from over. [5] - Following the rapid increase in gold prices, copper is expected to experience a rebound. The copper-to-gold ratio is at historically low levels, and the strategic importance of copper is rising due to global energy transition and the AI revolution, indicating a structural shortage cycle ahead. [5] Company Performance Summaries 奥来德 (688378.SH) - For the first three quarters of 2025, the company expects revenue between 370 to 400 million yuan, a year-on-year decrease of 13.75% to 20.22%. - The anticipated net profit attributable to shareholders is between 29 to 34 million yuan, reflecting a year-on-year decline of 66.42% to 71.36%. - The non-recurring net profit is expected to be between -6.7 to -5.6 million yuan, a significant decrease of 108.47% to 110.13%. [5] 利安隆 (300596.SZ) - The company achieved revenue of 4.509 billion yuan in the first three quarters of 2025, a year-on-year increase of 5.72%. - The net profit attributable to shareholders reached 392 million yuan, marking a year-on-year growth of 24.92%. - The continuous improvement in capacity utilization from new projects has led to enhanced scale effects and a corresponding increase in overall gross margin. [6] 煌上煌 (002695.SZ) - The company reported revenue of 1.379 billion yuan for the first three quarters of 2025, a year-on-year decline of 5.08%. - The net profit attributable to shareholders was 101 million yuan, showing a year-on-year increase of 28.59%. - The non-recurring net profit reached 88 million yuan, reflecting a year-on-year growth of 38.87%. [7] 燕京啤酒 (000729.SZ) - For the first three quarters of 2025, the company achieved revenue of 13.43 billion yuan, a year-on-year increase of 4.6%. - The net profit attributable to shareholders was 1.77 billion yuan, representing a year-on-year growth of 37.4%. - Structural upgrades and cost optimization have significantly improved profit margins. [8] 九洲药业 (603456.SH) - The company reported revenue of 4.16 billion yuan for the first three quarters of 2025, a year-on-year increase of 4.92%. - The net profit attributable to shareholders was 748 million yuan, reflecting a year-on-year growth of 18.51%. - The non-recurring net profit was 746 million yuan, marking a year-on-year increase of 20.67%. [9]